Associations of activated coagulation factor VII and factor VIIa-antithrombin levels with genome-wide polymorphisms and cardiovascular disease risk
Age-adjusted D-dimer to rule out deep vein thrombosis: findings from the PALLADIO algorithm
Aging of the venous valves as a new risk factor for venous thrombosis in the elderly: the BATAVIA study
Rivaroxaban reversal with prothrombin complex concentrate or tranexamic acid in healthy volunteers
ADAMTS-13 and von Willebrand factor: a dynamic duo
Receptor homodimerization plays a critical role in a novel dominant negative P2RY12 variant identified in a family with severe bleeding
Recommendations for future research in relation to pediatric pulmonary embolism: communication from the SSC of the ISTH
International collaborative study for the calibration of proposed International Standards for thromboplastin, rabbit, plain, and for thromboplastin, recombinant, human, plain
Effects of low-dose epinephrine on perioperative hemostasis and inflammatory reaction in major surgical operations: a randomized clinical trial
Cancer and risk of cerebral venous thrombosis: a case–control study
Platelet rescue by macrophage depletion in obese ADAMTS-13-deficient mice at risk of thrombotic thrombocytopenic purpura
Joint effects of prothrombotic genotypes and body height on the risk of venous thromboembolism: the Tromsφ study
The identification of at-risk patients and prevention of venous thromboembolism in pediatric cancer: guidance from the SSC of the ISTH
Characteristics and quality of oral anticoagulation treatment in pediatric patients in the Netherlands based on the CAPS cohort
Evaluation of a microfluidic flow assay to screen for von Willebrand disease and low von Willebrand factor levels
The ISTH Bleeding Assessment Tool and the risk of future bleeding
Use of factor concentrates for the management of perioperative bleeding: guidance from the SSC of the ISTH
Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides: reply
SIPPET: insights into factor VIII immunogenicity
Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin α-chain crosslinking
Timing and severity of inhibitor development in recombinant versus plasma-derived factor VIII concentrates: a SIPPET analysis
Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides: comment
External validation of the PLASMIC score: a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment
Natural antibodies to oxidation-specific epitopes: innate immune response and venous thromboembolic disease
Multimodal assessment of non-specific hemostatic agents for apixaban reversal
Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH
Contraceptive pills and thrombosis: effects of the French crisis on prescriptions and consequences for medicine agencies
Questions, questions, questions…
Philip J. Fay (1953–2014)
Non-myeloablative conditioning with busulfan before hematopoietic stem cell transplantation leads to phenotypic correction of murine Bernard-Soulier syndrome
Rivaroxaban vs. low molecular weight heparin for the prevention of venous thromboembolism after hip or knee arthroplasty: a cohort study
Histones induce phosphatidylserine exposure and a procoagulant phenotype in human red blood cells
Differential risks in men and women for first and recurrent venous thrombosis: the role of genes and environment
Paternal factor V Leiden and recurrent pregnancy loss: a new concept behind fetal genetics?: comment